NCT01653184View on ClinicalTrials.gov

Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Macular Degeneration
Interventions
DIETARY_SUPPLEMENT

Omega-3 fatty acid

The purpose of our study is to evaluate the change in serum omega-3 index (blood level of omega-3 fatty acids) after 1 gram of omega-3 fatty acid supplementation versus 2 grams.

Trial Locations (4)

18020

Mid Atlantic Retina - Bethlehem, Bethlehem

19006

Mid Atlantic Retina- Hungtindon Valley, Huntingdon Valley

19107

Mid Atlantic Retina- Wills Eye Institute, Philadelphia

08002

Mid Atlantic Retina- Cherry Hill, Cherry Hill

All Listed Sponsors
collaborator

Physician Recommended Nutriceuticals

INDUSTRY

lead

Wills Eye

OTHER

NCT01653184 - Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter